1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market Segmentation by Drug Type
4.3.2 Market Segmentation by Platform Type
4.3.3 Market Segmentation by Product Type
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Factors Driving E-Pharmacy Market in Europe
7.2 Covid Impact On E-Pharmacy Market
8 Market Opportunities & Trends
8.1 Rising E-Prescriptions Driving Online Pharmacies
8.2 Covid-19 Acting as A Catalyst for Online Pharmacies
8.3 Strategic Acquisitions to Expand Market for Online Pharmacy Vendors
8.4 Varied Product Offerings & Business Models, Competitive Pricing & Heavy Promotions
9 Market Growth Enablers
9.1 E-Pharmacies Enable Convenient Buying & Easy Availability of Medicines
9.2 Rising Prevalence of Chronic Diseases & Patient Population
9.3 Growing Internet Penetration & Improvement in Online Payment Modes
9.4 Growing Health Awareness & Self-Medication
10 Market Restraints
10.1 Illegal Online Pharmacy Practices & Stringent Regulatory Framework
10.2 Concerns with Data Breach & Privacy Issues
10.3 Competition from Hospitals & Brick-And-Mortar Pharmacies
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Insights by Medicine Type
11.2.2 Insights by Platform Type
11.2.3 Insights by Product
11.2.4 Insights by Geography
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Medicine Type
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 OTC Medicines
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 OTC Medicines: Geographical Segmentation
12.4 Prescription Medicines
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Prescription Medicines: Geographical Segmentation
13 Platform Type
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Mobile
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Mobile: Geographical Segmentation
13.4 Desktop
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Desktop: Geographical Segmentation
14 Product
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Medications
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Medications: Geography Segmentation
14.4 Health, Wellness & Nutrition
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Health, Wellness & Nutrition: Geographical Segmentation
14.5 Personal Care & Essentials
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Personal Care & Essentials: Geographical Segmentation
14.6 Others
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Others: Geographical Segmentation
15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 EU-5
16.1 Market Overview
16.2 Market Size & Forecast
16.2.1 EU-5: Medicine Segmentation
16.2.2 EU-5: Platform Type Segmentation
16.2.3 EU-5: Product Segmentation
16.3 Key Countries
16.3.1 Germany: Market Size & Forecast
16.3.2 UK: Market Size & Forecast
16.3.3 France: Market Size & Forecast
16.3.4 Italy: Market Size & Forecast
16.3.5 Spain: Market Size & Forecast
17 Central & Eastern Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.2.1 Central & Eastern Europe: Medicine Segmentation
17.2.2 Central & Eastern Europe: Platform Type Segmentation
17.2.3 Central & Eastern Europe: Product Segmentation
17.3 Key Countries
17.3.1 Poland: Market Size & Forecast
17.3.2 Netherlands: Market Size & Forecast
17.3.3 Russia: Market Size & Forecast
17.3.4 Switzerland: Market Size & Forecast
17.3.5 Czech Republic: Market Size & Forecast
17.3.6 Hungary: Market Size & Forecast
18 Nordic Countries
18.1 Market Overview
18.2 Market Size & Forecast
18.2.1 Nordic Countries: Medicine Segmentation
18.2.2 Nordic Countries: Platform Segmentation
18.2.3 Nordic Countries: Product Segmentation
18.3 Key Countries
18.3.1 Denmark: Market Size & Forecast
18.3.2 Sweden: Market Size & Forecast
18.3.3 Norway: Market Size & Forecast
18.3.4 Finland: Market Size & Forecast
18.3.5 Iceland: Market Size & Forecast
19 Competitive Landscape
19.1 Competition Overview
20 Key Company Profiles
20.1 ZUR ROSE GROUP
20.1.1 Business Overview
20.1.2 Key Strategies
20.1.3 Key Strengths
20.1.4 Key Opportunities
20.2 SHOP APOTHEKE
20.2.1 Business Overview
20.2.2 Key Strategies
20.2.3 Key Strengths
20.2.4 Key Opportunities
21 Other Prominent Vendors
21.1 AMX HOLDINGS
21.1.1 Business Overview
21.1.2 Key Strategies
21.1.3 Key Strengths
21.2 APTEKA.RU
21.2.1 Business Overview
21.2.2 Key Strategies
21.2.3 Key Strengths
21.3 APOTEA
21.3.1 Business Overview
21.3.2 Key Strategies
21.3.3 Key Strengths
21.4 APOTEKET
21.4.1 Business Overview
21.4.2 Key Strategies
21.4.3 Key Strengths
21.5 AZETA
21.5.1 Business Overview
21.5.2 Key Strategies
21.5.3 Key Strengths
21.6 BESTPHARMACY
21.6.1 Business Overview
21.6.2 Key Strategies
21.6.3 Key Strengths
21.7 CHEMIST4U
21.7.1 Business Overview
21.7.2 Key Strategies
21.7.3 Key Strengths
21.8 CHEMIST DIRECT
21.8.1 Business Overview
21.8.2 Key Strategies
21.8.3 Key Strengths
21.9 COCOONCENTER
21.9.1 Business Overview
21.9.2 Key Strategies
21.9.3 Key Strength
21.10 DEONLINEDROGIST
21.10.1 Business Overview
21.10.2 Key Strategies
21.10.3 Key Strengths
21.11 EURO-PHARMAS
21.11.1 Business Overview
21.11.2 Key Strategies
21.11.3 Key Strengths
21.12 EXPRESS PHARMACY
21.12.1 Business Overview
21.12.2 Key Strategies
21.12.3 Key Strengths
21.13 FARMACIA INTERNACIONAL
21.13.1 Business Overview
21.13.2 Key Strategies
21.13.3 Key Strengths
21.14 INDEX MEDICAL
21.14.1 Business Overview
21.14.2 Key Strategies
21.14.3 Key Strengths
21.15 INHOUSEPHARMACY
21.15.1 Business Overview
21.15.2 Key Strategies
21.15.3 Key Strengths
21.16 JUVALIS
21.16.1 Business Overview
21.16.2 Key Strengths
21.16.3 Key Strategies
21.17 LÉKÁRNA WPK
21.17.1 Business Overview
21.17.2 Key Strengths
21.17.3 Key Strategies
21.18 LLOYDS PHARMACY
21.18.1 Business Overview
21.18.2 Key Strategies
21.18.3 Key Strengths
21.19 MEDEXPRESS ENTERPRISES
21.19.1 Business Overview
21.19.2 Key Strategies
21.19.3 Key Strengths
21.20 MONCOINSANTÉ
21.20.1 Business Overview
21.20.2 Key Strategies
21.20.3 Key Strengths
21.21 MISTLETOE PHARMACY
21.21.1 Business Overview
21.21.2 Key Strategies
21.21.3 Key Strengths
21.22 MYCARE
21.22.1 Business Overview
21.22.2 Key Strategies
21.22.3 Key Strengths
21.23 PRVALEKARNA
21.23.1 Business Overview
21.23.2 Key Strategies
21.23.3 Key Strengths
21.24 MEDS
21.24.1 Business Overview
21.24.2 Key Strategies
21.24.3 Key Strengths
21.25 NEWPHARMA
21.25.1 Business Overview
21.25.2 Key Strategies
21.25.3 Key Strengths
21.26 OXFORD ONLINE PHARMACY
21.26.1 Business Overview
21.26.2 Key Strategies
21.26.3 Key Strengths
21.27 PARAFARMACIA-ONLINE
21.27.1 Business Overview
21.27.2 Key Strategies
21.27.3 Key Strengths
21.28 PHARMACY2U
21.28.1 Business Overview
21.28.2 Key Strategies
21.28.3 Key Strengths
21.29 PHARMACY DIRECT GB
21.29.1 Business Overview
21.29.2 Key Strategies
21.29.3 Key Strengths
21.30 PROTEK GROUP
21.30.1 Business Overview
21.30.2 Key Strategies
21.30.3 Key Strengths
21.31 SBER EAPTEKA
21.31.1 Business Overview
21.31.2 Key Strategies
21.31.3 Key Strengths
21.32 SIMPLE ONLINE PHARMACY
21.32.1 Business Overview
21.32.2 Key Strategies
21.32.3 Key Strengths
21.33 THE INDEPENDENT PHARMACY
21.33.1 Business Overview
21.33.2 Key Strategies
21.33.3 Key Strengths
21.34 THE FRENCH PHARMACY
21.34.1 Business Overview
21.34.2 Key Strategies
21.34.3 Key Strengths
21.35 UK MEDS DIRECT
21.35.1 Business Overview
21.35.2 Key Strategies
21.35.3 Key Strengths
21.36 WEBMED PHARMACY
21.36.1 Business Overview
21.36.2 Key Strategies
21.36.3 Key Strengths
21.37 LEKARNAR
21.37.1 Business Overview
21.37.2 Key Strategies
21.37.3 Key Strengths
21.38 PHARM24
21.38.1 Business Overview
21.38.2 Key Strategies
21.38.3 Key Strengths
21.39 PHARMACY4U
21.39.1 Business Overview
21.39.2 Key Strategies
21.39.3 Key Strengths
21.40 VAMIDA
21.40.1 Business Overview
21.40.2 Key Strategies
21.40.3 Key Strengths
22 Report Summary
22.1 Key Takeaways
22.2 Strategic Recommendations
23 Quantitative Summary
23.1 Market by Medicine
23.1.1 Eu-5: Medicine Type Segmentation
23.1.2 Central & Eastern Europe: Medicine Type Segmentation
23.1.3 Nordic Countries: Medicine Type Segmentation
23.2 Market by Platform
23.2.1 EU-5: Platform Segmentation
23.2.2 Central & Eastern Europe: Platform Segmentation
23.2.3 Nordic Countries: Platform Segmentation
23.3 Market by Product
23.3.1 Eu-5: Product Type Segmentation
23.3.2 Central & Eastern Europe: Product Segmentation
23.3.3 Nordic Countries: Product Segmentation
23.4 Market by Geography
23.4.1 OTC: Geographical Segmentation
23.4.2 Prescription: Geographical Segmentation
23.4.3 Mobile Platform: Geographical Segmentation
23.4.4 Desktop Platform: Geographical Segmentation
23.4.5 Medications: Geographical Segmentation
23.4.6 Health, Wellness & Nutrition: Geographical Segmentation
23.4.7 Personal Care & Essentials: Geographical Segmentation
23.4.8 Others: Geographical Segmentation
24 Appendix
24.1 Abbreviations